1,240 Shares in The Clorox Company (NYSE:CLX) Purchased by Vision Capital Management Inc.

Vision Capital Management Inc. acquired a new position in shares of The Clorox Company (NYSE:CLX) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,240 shares of the company’s stock, valued at approximately $201,000.

Several other hedge funds have also bought and sold shares of the business. Money Concepts Capital Corp boosted its stake in Clorox by 3.3% during the fourth quarter. Money Concepts Capital Corp now owns 22,056 shares of the company’s stock worth $3,582,000 after acquiring an additional 697 shares in the last quarter. Lion Street Advisors LLC lifted its stake in shares of Clorox by 10.0% in the fourth quarter. Lion Street Advisors LLC now owns 5,294 shares of the company’s stock worth $860,000 after buying an additional 480 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Clorox by 21.3% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,508 shares of the company’s stock worth $3,013,000 after buying an additional 3,249 shares in the last quarter. Verity Asset Management Inc. lifted its stake in shares of Clorox by 8.4% in the fourth quarter. Verity Asset Management Inc. now owns 3,110 shares of the company’s stock worth $501,000 after buying an additional 241 shares in the last quarter. Finally, Boston Trust Walden Corp lifted its stake in shares of Clorox by 4.0% in the fourth quarter. Boston Trust Walden Corp now owns 284,821 shares of the company’s stock worth $46,258,000 after buying an additional 10,913 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 1.5 %

Shares of CLX stock opened at $145.98 on Thursday. The company has a market capitalization of $18.07 billion, a price-to-earnings ratio of 50.86, a PEG ratio of 2.92 and a beta of 0.42. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company’s fifty day moving average price is $162.25 and its 200-day moving average price is $158.76. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period in the prior year, the company posted $2.16 EPS. Sell-side analysts expect that The Clorox Company will post 6.86 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.34%. Clorox’s dividend payout ratio is currently 170.04%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several analyst reports. Barclays upped their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, DA Davidson reduced their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $158.21.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.